LISBON, Portugal — A shift toward broader-spectrum antibiotics and increasing antibiotic resistance has led to high levels of mortality and neurodevelopmental impacts in surviving babies, according to ...
A multi-centric study in India begins to combat antimicrobial-resistant neonatal sepsis, aiming to save newborn lives through ...
14d
Jipmer enrolls first infant in NeoSep1 international clinical trial in fight against neonatal sepsis
Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.
Health and Me on MSN
Sepsis: India joins global trial to screen newborns for deadly drug-resistant infections
The NeoSep1 trial is expected to enroll 3,000 newborns across Asia and Africa by the end of 2028. Along with India, newborns have already been enrolled in Ghana, Kenya, and South Africa. Hospitals in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results